It's because of the CR. diluted the share price. I think the market suspect there would be another CR due to lack of cash flow. Some on should go and wake up their sales team.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025